-
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
- Sang Heon Han, Hyeong Dong Yuk
-
J Urol Oncol. 2023;21(1):32-44.
-
Original Article
Mar 31, 2023
The Landscape of Epidemiology in Urologic Cancers
|
-
Complex Epidemiology of Prostate Cancer in Asian Countries
- Kagenori Ito, Takahiro Kimura
-
J Urol Oncol. 2023;21(1):5-13.
-
Review Article
Mar 31, 2023
|
-
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
- Chang Wook Jeong
-
J Urol Oncol. 2024;22(1):4-10.
-
Invited Review
Mar 31, 2024
Prostate Cancer
|
-
Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
- Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, et al.
-
J Urol Oncol. 2024;22(2):144-149.
-
Invited Review
Jul 31, 2024
Prostate Cancer
|
-
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
- Jung Sik Huh, Kyung Kgi Park
-
J Urol Oncol. 2023;21(2):121-127.
-
Original Article
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
- Sang Hun Song, Jong Jin Oh
-
J Urol Oncol. 2023;21(2):154-164.
-
Invited Review
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
- Jung Hoon Kim, Ji Woong Hwang
-
J Urol Oncol. 2024;22(1):42-51.
-
Original Article
Mar 31, 2024
Kidney Cancer
|
-
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
- Byung Kwan Park
-
J Urol Oncol. 2023;21(2):106-111.
-
Invited Review
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
- Yongsoo Jo, Hyeong Dong Yuk
-
J Urol Oncol. 2024;22(3):256-267.
-
Invited Review
Nov 30, 2024
Bladder Cancer
|
-
Current Update on Prostate Cancer Immunotherapy
- Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
-
J Urol Oncol. 2023;21(1):14-22.
-
Review Article
Mar 31, 2023
|
-
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database
- Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, et al.
-
J Urol Oncol. 2023;21(1):45-52.
-
Original Article
Mar 31, 2023
|
-
The Predictive Value of the Preoperative Systemic Inflammatory Response Indices in Non–Organ-Confined Disease in Upper Urinary Tract Urothelial Carcinoma
- Sung Kyung Choi, Chan Hoon Gwak, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(2):174-180.
-
Original Article
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma
- Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al.
-
J Urol Oncol. 2023;21(3):183-199.
-
Invited Review
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|
-
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
- Chan Woo Wee, Jaeho Cho
-
J Urol Oncol. 2023;21(3):217-227.
-
Invited Review
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|
-
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
- Jiwoong Yu, Hyun Hwan Sung
-
J Urol Oncol. 2023;21(3):228-240.
-
Invited Review
Nov 30, 2023
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
|
-
Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy
- Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.
-
J Urol Oncol. 2023;21(3):249-256.Correction in: 2024;22(2):183
-
Original Article
Nov 30, 2023
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
|
-
Early Experience With Pembrolizumab in Bacillus Calmette-Guérin Unresponsive Non–Muscle-Invasive Bladder Cancer
- Chung Un Lee, Wan Song, Minyong Kang, et al.
-
J Urol Oncol. 2023;21(3):241-248.
-
Topic Article
Nov 30, 2023
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
|
-
Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
- Sung Han Kim, Ilma S. Savul, Seth P. Lerner
-
J Urol Oncol. 2024;22(1):68-77.
-
Invited Review
Mar 31, 2024
Bladder Cancer
|
-
Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review
- Minseok Suh, Gi Jeong Cheon
-
J Urol Oncol. 2024;22(1):11-20.
-
Invited Review
Mar 31, 2024
Prostate Cancer
|
-
Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
- Joohyun Hong, Ghee Young Kwon, Minyong Kang, et al.
-
J Urol Oncol. 2024;22(1):59-67.
-
Original Article
Mar 31, 2024
Kidney Cancer
|
-
Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis
- Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, et al.
-
J Urol Oncol. 2024;22(1):34-41.
-
Systemic Review and Meta-analysis
Mar 31, 2024
Kidney Cancer
|
-
Robot-Assisted Radical Nephrectomy With Inferior Vena Cava Thrombectomy: A Narrative Review With Step-by-Step Procedures
- Seokhwan Bang, Sung-Hoo Hong
-
J Urol Oncol. 2024;22(2):105-114.
-
Invited Review
Jul 31, 2024
Renal Cell Carcinoma
|
-
Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
- Bokyung Ahn, Jinahn Jeong, Yong Il Lee, et al.
-
J Urol Oncol. 2024;22(2):115-127.
-
Invited Review
Jul 31, 2024
Renal Cell Carcinoma
|
-
Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series
- Jae Hoon Chung, Hwanik Kim, Woo Jin Bang, et al.
-
J Urol Oncol. 2024;22(3):188-195.
-
Original Article
Nov 30, 2024
Prostate Cancer
|
-
The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
- Jong Ho Park, Jong Jin Oh
-
J Urol Oncol. 2024;22(3):246-255.
-
Invited Review
Nov 30, 2024
Bladder Cancer
|
-
Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
- Gabriela M. Diaz, Peter S. Palencia, Michael S. Leapman
-
J Urol Oncol. 2025;23(1):4-13.
-
Invited Review
Mar 31, 2025
Prostate Cancer
|
-
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies
- Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, et al.
-
J Urol Oncol. 2023;21(1):23-31.
-
Review Article
Mar 31, 2023
|
-
Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey
- Joongwon Choi, Cheryn Song, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(1):59-69.
-
Original Article
Mar 31, 2023
|
-
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
- Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al.
-
J Urol Oncol. 2023;21(1):70-78.
-
Original Article
Mar 31, 2023
|
-
The Prognostic Significance of Body Mass Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma
- Hee Jae Yoo, Sun Il Kim, Se Joong Kim, et al.
-
J Urol Oncol. 2023;21(1):88-94.
-
Original Article
Mar 31, 2023
|